Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Liabilities and Shareholders Equity (2024 - 2025)

Historic Liabilities and Shareholders Equity for Kestra Medical Technologies (KMTS) over the last 2 years, with Q4 2025 value amounting to $246.7 million.

  • Kestra Medical Technologies' Liabilities and Shareholders Equity changed N/A to $246.7 million in Q4 2025 from the same period last year, while for Oct 2025 it was $916.7 million, marking a year-over-year increase of 189511.63%. This contributed to the annual value of $295.7 million for FY2025, which is 54363.53% up from last year.
  • Kestra Medical Technologies' Liabilities and Shareholders Equity amounted to $246.7 million in Q4 2025.
  • Over the past 5 years, Kestra Medical Technologies' Liabilities and Shareholders Equity peaked at $295.7 million during Q2 2025, and registered a low of $45.9 million during Q2 2024.